Status:
COMPLETED
Secondary Prevention and Application-based Lifestyle Support for Patients With Intermittent Claudication
Lead Sponsor:
Malmö University
Collaborating Sponsors:
Skane University Hospital
Conditions:
Intermittent Claudication
Vascular Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A randomized controlled pilot trial will be used to test Lifepod®PAD as secondary prevention support system. Approximately 60 patients with intermittent claudication at the Department of vascular dise...
Detailed Description
A randomized controlled pilot trial will be used to test the application-based support systems Lifepod®PAD that are developed in collaboration with Cross Technology Solutions based on results from our...
Eligibility Criteria
Inclusion
- Patients with intermittent claudication diagnosed at the Department of vascular diseases at Skåne University hospital.
- The participants should have access to a smartphone or tablet and be able to speak and understand Swedish.
Exclusion
- Patients with intermittent claudication who are considered for revascularization.
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04390282
Start Date
September 1 2021
End Date
February 28 2022
Last Update
April 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Christine Kumlien
Malmo, Sweden, 20506